rheumatology & Musculoskeltal

---

NIHR Portfolio Studies:

BSRBR: Toxicity from Biological Therapy
Principal Investigator: Dawn Collier, Research Nurse
​Sponsor: University of Manchester
The BSRBR-RA study tracks the progress of people with rheumatoid arthritis (RA) who have been prescribed biologic (including biosimilar) and other targeted therapies in the UK to monitor the long-term safety of these drugs.
​

       IMID BioResource
       Principal Investigator: Tara Lees
       Sponsor: Manchester University NHS Foundation Trust
                                                        Working with the NIHRBR, we are proposing to develop a centralised national recallable bioresource of                                                                16,000 patients and relatives of patients with one or more of a spectrum of disorders which comprise                                                                immune-mediated inflammatory diseases (IMIDs), to support scientific and clinical IMID research. 

---

---